Skip to main content
Caplight Logo









Strekin AG

Strekin AG

Private
BaselHealthcare & Life Scienceshttps://strekin.com

Last Round

Series A

Sep 3, 2019

Total Funding Raised

$13.16M

Company Overview

Strekin AG operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Series A round in September 2019.

Strekin AG is a clinical-stage biopharmaceutical company that develops novel therapeutics for diseases involving cell stress-related inflammatory pathways.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Strekin AG Comparables

Compare Strekin AG with similar companies based on industry and business-model similarity.

Strekin AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hoba Therapeutics
85%
Spiral Therapeutics
85%
AudioCure Pharma
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Strekin AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 3, 2019
Seed CMay 31, 2017
SeedMar 1, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 7, 2025

    Monthly visitors grew 1052% MoM, from 211 to 2.4K.

  • May 2, 2025

    Monthly visitors grew 336% MoM, from 211 to 919.

Book a demo to see all signals

For institutional investors. Book with your work email.

Strekin AG Filings

Explore SEC and related filing metadata, where available.

Strekin AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Strekin AG's valuation, stock price, and market status.

Is Strekin AG a public or private company?

Strekin AG is a private company.

What is the current stock price of Strekin AG?

Strekin AG is a private company, so its shares have no public market price. Caplight tracks Strekin AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Strekin AG worth (valuation)?

Valuation information for Strekin AG is not publicly available.

Can I buy Strekin AG stock?

Strekin AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Strekin AG's last funding round?

Strekin AG's most recent funding round was Series A on September 3, 2019.

Who are the main investors in Strekin AG?

Investor information for Strekin AG is not publicly disclosed.

Will Strekin AG IPO soon?

No public IPO plans have been announced for Strekin AG.

How can I track Strekin AG secondary market activity?

Caplight tracks bids, offers, and trades in Strekin AG's shares on secondary markets.

Firmographic Details

HeadquartersBasel
Year Founded2014
Last FundingSep 3, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?